OR2AO1P

Across TCGA pan-cancer cohorts, OR2AO1P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated OR2AO1P data layer.

The strongest signal is observed in mesothelioma (MESO), where higher OR2AO1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR2AO1P expression acts as an unfavorable survival marker, although some lineages such as ACC and BLCA show a favorable association.

MESO, SKCM, and ACC are the cancer types where OR2AO1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	IV	0.036	0.602	<.001	105	view →
SKCM	DFS	Tertile	III,IV	0.337	0.646	<.001	75	view →
ACC	DFS	Tertile	II,III,IV	0.889	0.286	.010	48	view →
STAD	DFS	Median	II,III,IV	0.433	0.632	<.001	28	view →
KIRC	DFS	Tertile	IV	0.224	0.549	.006	23	view →
THCA	DFS	Tertile	IV	0.335	0.710	.027	19	view →
LGG	OS	Tertile	All	0.594	0.908	.001	18	view →
BLCA	OS	Median	IV	0.577	0.366	.004	13	view →
CHOL	OS	Quartile	III,IV	0.300	0.922	.038	9	view →
COAD	OS	Tertile	IV	0.812	0.352	.017	9	view →
LIHC	DFS	Tertile	III,IV	0.199	0.391	.033	9	view →
READ	DFS	Tertile	All	0.359	0.686	.034	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

OR2AO1P–MESO (OS)

Open the MESO breakdown →